ACCORD BIOPHARMA Trademark
ACCORD BIOPHARMA is a USPTO trademark filed by Accord BioPharma, Inc.. Status: Registered.
Trademark Facts
| Mark | ACCORD BIOPHARMA |
|---|---|
| Serial Number | 98763913 |
| Registration Number | 7898294 |
| Status | Registered |
| Filing Date | 2024-09-23 |
| Registration Date | 2025-08-19 |
| Mark Type | Word |
| Nice Classes | 009 (Electronics & Software), 036 (Financial Services), 041 (Education & Entertainment), 042 (Software & IT) |
| Owner | Accord BioPharma, Inc. |
| Attorney of Record | Michele K. Robichaux |
| Prosecution Events | 15 |
| Latest Event | R.PR on 2025-08-19 |
Goods & Services
Providing online non-downloadable videos featuring information regarding therapies and treatment options in the fields of oncology, immunology, and critical care; Downloadable software for managing medical office inventories of pharmaceutical preparations; Providing insurance information in the form of answers to questions from healthcare providers and patients about medication insurance coverage, insurance reimbursement, insurance payer policies and patient financial assistance; healthcare insurance administration services in the field of benefit verification services, prior authorization support and information, billing and claims processing support, and claims appeal support; providing information about healthcare insurance, patient financial assistance, and patient insurance reimbursement programs including enrollment requirements; "BIOPHARMA"; Providing on-line, non-downloadable, Internet-based software applications for providing, exchanging, retrieving and analyzing health and healthcare information; providing a website featuring technology enabling users to exchange, retrieve and analyze health and healthcare information; providing medical and scientific research information in the field of clinical and drug information to medical professionals for use in medical education in the field of oncology, immunology, and critical care; providing medical and scientific research information to medical professionals in the field of oncology, immunology, and critical care pharmaceuticals and clinical trials